105 results

• FDA Announces New Recommendations for Acceptable Limits of Nitrosamine in Drugs

  August 9, 2023

  Irvin Jackson

  The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.

• Drugs Advertised on TV Often Have Low Therapeutic Value, Study Finds

  January 26, 2023

  Irvin Jackson

  Harvard researchers warn that drug companies spend billions of dollars advertising medications which are not as effective, and often more expensive, than other options, researchers warn.

• Chantix Recall Lawsuits Over Cancer Risk Consolidated in Southern District of New York

  January 13, 2023

  Irvin Jackson

  All Chantix recall cancer lawsuits are to be consolidated in a southern New York federal court for pretrial proceedings.

• Nitrosamines Problems Are More Widespread in Drugs Than FDA Anticipated: Report

  November 1, 2022

  Irvin Jackson

  The FDA has been caught off-guard by the number of drugs being recalled for nitrosamine contamination and is likely to update a 2020 guidance to better address the problem according to a recent report.

• Consolidation of Chantix Recall Lawsuits to Be Considered By JPML in December

  October 21, 2022

  Irvin Jackson

  A panel of federal judges will decide whether to create a Chantix recall lawsuits multidistrict litigation following oral arguments scheduled for December 1.

• MDL Sought for Chantix Lawsuits Over Cancer-Causing Contaminants

  September 6, 2022

  Russell Maas

  A motion has been filed to consolidate all Chantix lawsuits before one judge for pretrial proceedings in federal court.

• Class Action Lawsuit Filed Over Presence of Toxic Chemicals in Chantix

  December 1, 2021

  Irvin Jackson

  A class action lawsuit claims the presence of potentially cancer-causing chemicals made Chantix an illegal and unadulterated drug which was never approved by the FDA.

• Class Action Lawsuit Over Chantix Nitrosamine Impurities Filed Against Pfizer

  October 18, 2021

  Irvin Jackson

  A class action lawsuit filed after a recent Chantix recall claims the drug was illegally marketed due to the lack of warnings that it may contain cancer-causing substances.

• Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination

  October 15, 2021

  Irvin Jackson

  Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.

• Generic Chantix Launched Following Recall of Name Brand Drug Due To Toxic Contaminant

  September 27, 2021

  Irvin Jackson

  The first generic version of Chantix has been announced just days after a complete recall of the brand name smoking cessation drug.